The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response (Q44567289)

4 December 2017

title

The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response (English)

1 reference

4 December 2017

Yadi Wu

1

1 reference

4 December 2017

Yanping Wang

2

1 reference

4 December 2017

Cuiping Zhong

3

1 reference

4 December 2017

Yuanchao Li

4

1 reference

4 December 2017

Xiaoyu Li

5

1 reference

4 December 2017

Bing Sun

6

1 reference

4 December 2017

publication date

1 October 2003

1 reference

International Immunopharmacology

4 December 2017

published in

1 reference

4 December 2017

volume

3

1 reference

4 December 2017

issue

10-11

1 reference

4 December 2017

page(s)

1457-1465

1 reference

Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Pathology of experimental autoimmune uveoretinitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Inhibition of type II collagen-induced arthritis in rats by triptolide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

A clinical trial of FK506 in refractory uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Suppressive effects of Tripterygium wilfordii Hook f., a traditional Chinese medicine, on collagen arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Triptolide induces apoptotic death of T lymphocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

FK506 and rapamycin: novel pharmacological probes of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900144-9

7 January 2021

10.1016/S1567-5769(03)00144-9

Identifiers

DOI

1 reference

4 December 2017

1 reference